Preclinical Profile of PRS-220, a Novel Inhaled Inhibitor of CTGF/CCN2 in Clinical Development for Idiopathic Pulmonary Fibrosis

Autor:	V. Neiens, M. Pavlidou, C. Wurzenberger, T. Jaquin, E.-M. Hansbauer, A. Konitsiotis, T. Mosebach, M. Richter, A. Fysikopoulos, J. Peper-Gabriel, K. Heinig, G. Matschiner, S. Olwill
Rok vydání:	2023
Zdroj:	A67. BIOMARKERS, MEDIATORS, AND TRANSLATIONAL MODELS FOR ILD.
DOI:	10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2246
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3f139f633d5b3679659abd04e5684eae https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2246 Zobrazit plný text záznamu